If the hypothesis is that dysregulation of ANK1, leading to reduced AnkR expression, PNN integrity and Kv3.1b channel density in PV+ cells, could be a critical pathomechanism in AD, then future strategies aimed at upregulating neuronal AnkR protein levels or PNNs could prove therapeutically beneficial. The gene discussed is ANK1; the disease is Alzheimer disease.